PTPRC and neoplasm: Our results show that the combined treatment with αPD-L1 and Salmonella led to a significant 1.7-fold increase in the infiltration of CD45+ immune cells into the tumor site compared to the control group (~18% vs. 31%) (Figures 8A, B).